Skip to nav Skip to content

Moffitt Presentations at SSO 2025 

Note - all times are listed as EST
  • Thursday, March 27 - Sessions & Symposiums

    13. Intratumorally delivered conventional type I dendritic cells in de novo stage 4 HER2 breast cancer patients lead to reduction in primary breast cancer and metastasis
    Oral Abstract Session
    Paige Aiello
    8:34 - 8:40 a.m.
    Room 122-123

    47. A cohort study of factors associated with survival and chronic aspirin use in colorectal cancer
    Oral Abstract Session
    Leah Hendrick
    2:42 - 2:48 p.m.
    Room 122-123

    Impact of Contemporary High-Impact Trials on Surgical Management of Patients with Sarcoma / Talk Title: The optimal duration of imatinib for patients with high-risk GIST
    Symposium
    Mihaela Druta, MD
    2:43 - 3:08 p.m.
    Ballroom A

    John Mullinax, MD
    3:30 - 5:30 p.m.
    Pan-Tumor HUB Zone

    P43. Investigation of patient-derived organoid models as a system to study individualized therapy for colorectal cancer
    Oral Abstract Session
    Leah Hendrick
    4:08 - 4:14 p.m.
    Room 124-125

    P158. Collagenolysis by Enterococcus faecalis induces DDR1 signaling, proliferation and immune evasion in colorectal cancer
    Oral Abstract Session
    Richard Jacobson
    9:30 - 9:36 p.m.
    Room 124-125

  • Friday, March 28 - Sessions and Symposiums

    73. Symposium: Uncommon Colorectal Malignancies & Challenging Clinical Situations
    Oral Abstract Session
    Rachel Voss, MD, MPH
    8:00 - 8:09 a.m.
    Ballroom A

    Cross Disciplinary Patient Care in Surgical Oncology / Talk Title: Growing a Practice Together: Mentorship and Education in a Cross Disciplinary Practice
    Symposium
    Vernon Sondak, MD
    8:15 - 8:30 p.m.
    Ballroom D

    68. A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
    Oral Abstract Session
    Michelle Dugan
    9:13 - 9:19 a.m.
    Room 122-123

    Cross Disciplinary Patient Care in Surgical Oncology / Talk Title: Financial Sustainability in Utilizing APP’s within the Multidisciplinary Program: Program Location (Outpatient/Telehealth vs Inpatient/Facility Based) & Billing Incident to Provide vs Spit/Shared Billing
    Symposium
    David Johnson, PA-C
    9:15 - 9:30 a.m.
    Ballroom D

    105. Intra-tumoral mucolytic therapy for patients with unresectable pseudomyxoma peritonei: Results of an expanded access program
    Oral Abstract Session
    Michael Wach, MD
    1:26 - 1:32 p.m.
    Room 124-125

    P198. Evaluating the relationship between anemia, transfusion, and thromboembolic events in surgical geriatric cancer patients: a national study
    Oral Abstract Session
    Leah Hendrick
    4:41 - 4:47 p.m.
    Room 124-125

  • Saturday, March 29 - Symposium

    Symposium Title: Newly Approved FDA Therapies for Melanoma / Talk Title: Percutaneous Liver Perfusion Future Directions, Unanswered Questions
    Symposium
    Jonathan Zager, MD
    9:30 - 9:45 a.m.
    Ballroom A